Company Cash Funds: kinetabio.com (KA)

Public company logo of Kineta Bio (KA)

Kineta, Inc. (KA) is developing advanced methods to combat resistant solid tumors, targeting the expansive precision oncology market. Changes in cash and cash equivalents demonstrate the issuer's liquidity, with the 0.00 level serving as a critical benchmark. Management is currently seeking ways to capitalize on existing developments following a hiatus in research. The company aims to confirm the efficacy of drugs that suppress immunosuppression within neoplasms.

KA - Kineta Bio Company Cash Volume over the range 04/28/2023 - 09/28/2024

Summary analytical data breakdowns for Kineta Inc (KA)

- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
Comprehensive company analysis:kinetabio.com
Product sample of Kineta

Shifting antibody production to the contract facilities of Kineta, Inc. (KA) shifts the control focus toward liquidity management. This metric measures the volume of available cash, determining the company's ability to fund R&D without incurring external debt. Stable reserves prevent cash flow gaps, although excess funds may signal low investment efficiency. By analyzing the cash balance, an investor assesses the financial stability of the business.

Main competitors

Company Cash on Hand IBRX (ImmunityBio Corp)|Company Total Cash Amount IMCR|Company Cash Volume JANX (Janux Therapeutics, Inc.)|Company Cash Balance RCUS|zymeworks.com - Company Cash Volume|Company Cash Reserve Tango Therapeutics Corp|Iovance Biotherapeutics (IOVA) - Company Cash Funds|Immatics N.V. - Company Cash Balance|XNCR (xencor.com) - Company Cash Volume|Company Cash Volume Compass Therapeutics Inc|Company Cash Funds Replimune (REPL)|LYEL: Company Total Cash Volume|Innate Pharma SA - Company Cash on Hand|Pyxis Oncology, Inc. (PYXS) - Company Cash Reserve|Compugen - Company Cash Volume|Company Liquid Assets IO Biotech Inc IOBT|STRO (Sutro Biopharma Inc.) - Company Cash on Hand|INKT - Company Liquid Assets|Company Cash Funds werewolftx.com|Company Cash on Hand Immix Biopharma, Inc. (IMMX)|Company Cash on Hand ALXO (ALX Oncology Holdings)|Company Cash Funds CUE (Cue Biopharma)|Company Cash Volume PDSB (PDS Biotechnology Corp)|sonnetbio.com (SONN) - Company Cash Reserve|MAIA Biotechnology - Company Cash Volume|LIMN - Company Cash Volume|LVTX: Company Cash Volume|NextCure - Company Cash Balance|LPTX (Leap Therapeutics Inc) - Company Cash Volume|INTS (Intensity Therapeutics, Inc.) - Company Total Cash Amount|Company Cash Volume SNSE|Company Cash Funds TOVX (Theriva Biologics, Inc.)|Gritstone bio, Inc. - Company Cash on Hand|Company Cash Balance NEXI|turnstonebio.com - Company Cash Volume|VCNX (Vaccinex, Inc) - Company Cash and Cash Equivalents|Harpoon Therapeutics (HARP) - Company Cash Funds